Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL From Oxidative Modification in Hypercholesterolemic Rabbits.

Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.23.570
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Antimetastatic and Antitumorigenic Effects in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-Metastatic and Anti-Tumorigenic Effects in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Effects of an HMG-CoA Reductase Inhibitor on Cytokine Production by Human Monocytes/Macrophages.

Journal of Nippon Medical School
1995English

Mechanism of HMG-CoA Reductase Inhibitor-Induced Contractile Dysfunction in Rat Cultured Skeletal Muscle

Biophysical Journal
Biophysics
2012English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
2002English

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

Risk Factors and Serum Cholesterol Concentrations in the Patients Given HMG-CoA Reductase Inhibitor, Pravastatin

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2005English

Characterization of an HMG-CoA Reductase From Listeria Monocytogenes That Exhibits Dual Coenzyme Specificity

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy